Patents by Inventor Birgitte Winther Lund

Birgitte Winther Lund has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds with activity at estrogen receptors
    Patent number: 8822548
    Abstract: Disclosed herein are methods of treatment and prevention of diseases and disorders related to estrogen receptors comprising administering novel di-aromatic compounds to patients in need thereof.
    Type: Grant
    Filed: October 29, 2010
    Date of Patent: September 2, 2014
    Assignee: Acadia Pharmaceuticals Inc.
    Inventors: Roger Olsson, Lene Hyldtoft, Fabrice Piu, Magnus Gustafsson, Vladimir Sherbukhin, Birgitte Winther Lund
  • Compounds with activity at estrogen receptors
    Patent number: 8101651
    Abstract: Disclosed herein are compounds of Formula I as disclosed herein, methods of modulating the activity of an estrogen receptor and methods of treating a disorder associated with estrogen receptors.
    Type: Grant
    Filed: October 24, 2008
    Date of Patent: January 24, 2012
    Assignee: Acadia Pharmaceuticals Inc.
    Inventors: Roger Olsson, Lene Hyldtoft, Magnus Gustafsson, Birgitte Winther Lund
  • COMPOUNDS WITH ACTIVITY AT ESTROGEN RECEPTORS
    Publication number: 20110046237
    Abstract: Disclosed herein are methods of treatment and prevention of diseases and disorders related to estrogen receptors comprising administering novel di-aromatic compounds to patients in need thereof.
    Type: Application
    Filed: October 29, 2010
    Publication date: February 24, 2011
    Applicant: ACADIA PHARMACEUTICALS INC.
    Inventors: Roger OLSSON, Lene HYLDTOFT, Fabrice PIU, Magnus GUSTAFSSON, Vladimir SHERBUKHIN, Birgitte WINTHER LUND
  • Compounds with activity at estrogen receptors
    Patent number: 7825265
    Abstract: Disclosed herein are novel di-aromatic compounds and methods for using various di-aromatic compounds for treatment and prevention of diseases and disorders related to estrogen receptors.
    Type: Grant
    Filed: November 8, 2005
    Date of Patent: November 2, 2010
    Assignee: ACADIA Pharmaceuticals Inc.
    Inventors: Roger Olsson, Lene Hyldtoft, Fabrice Piu, Magnus Gustafsson, Vladimir Sherbukhin, Birgitte Winther Lund
  • AMINOPHENYL DERIVATIVES AS SELECTIVE ANDROGEN RECEPTOR MODULATORS
    Publication number: 20090270449
    Abstract: Disclosed herein is a novel class of aminophenyl compounds having the structure: wherein R1 is cyano or nitro and ring A is a bi- or tricyclic bridged heterocycle and to their use as modulators of androgen receptor for the treatment or prevention of conditions relating thereto.
    Type: Application
    Filed: June 30, 2009
    Publication date: October 29, 2009
    Inventors: NATHALIE SCHLIENGER, Mikkel Boas Thygesen, Jan Pawlas, Fabrizio Badalassi, Rasmus Lewinsky, Birgitte Winther Lund, Roger Olsson
  • Aminophenyl derivatives as selective androgen receptor modulators
    Patent number: 7585877
    Abstract: Disclosed herein is a novel class of aminophenyl compounds having the structure: wherein R1 is cyano or nitro and ring A is a bi- or tricyclic bridged heterocycle and to their use as modulators of androgen receptor for the treatment or prevention of conditions relating thereto.
    Type: Grant
    Filed: January 9, 2006
    Date of Patent: September 8, 2009
    Inventors: Nathalie Schlienger, Mikkel Boas Thygesen, Jan Pawlas, Fabrizio Badalassi, Rasmus Lewinsky, Birgitte Winther Lund, Roger Olsson
  • Androgen receptor modulators and method of treating disease using the same
    Patent number: 7268232
    Abstract: Disclosed herein are bicycloaryl compounds of Formula (I) that selectively modulate nuclear receptors, preferably the androgen receptor, or a pharmaceutically acceptable salt, ester, amide, or prodrug thereof, and methods of treating disease comprising administering a compound of Formula (I) to a patient in need thereof.
    Type: Grant
    Filed: May 16, 2005
    Date of Patent: September 11, 2007
    Assignee: Acadia Pharmaceuticals Inc.
    Inventors: Nathalie Schlienger, Jan Pawlas, Alma Fejzic, Roger Olsson, Birgitte Winther Lund, Fabrizio Badalassi, Rasmus Lewinsky, Mikkel Boas Thygesen